Keyphrases
Breast Cancer Cell Migration
28%
Lactate Metabolism
28%
Metabolic Modulation
28%
Immunoproteomic Analysis
28%
Autoantibody Response
28%
MMP-8
28%
Gene Variation
28%
Immunologic Constant of Rejection
28%
Tumor Microbiome
28%
MiRNA Signature
28%
Immunogenomics
28%
Her2neu
28%
Primary Breast Cancer
28%
Immune Checkpoint Inhibitors
28%
Early Breast Cancer
28%
Genetic Dysregulations
28%
Obesity Paradox
28%
Tumor Immunology
28%
Tumor Immunotherapy
28%
NY-ESO-1
28%
PRAME
28%
Autoantibody Repertoire
28%
MicroRNA Regulatory Network
28%
Transcriptomic Network
28%
Therapeutic Molecular Targets
28%
TIMP3
28%
Genetic Polymorphism
28%
Breast Carcinoma
28%
Collagenase-2
28%
Autoantibody Detection
28%
DNA Damage Response
28%
Immune-related lncRNA
28%
Prognostic Score
28%
Family Members
28%
BRCA1-associated Protein 1 (BAP1)
28%
BRCA mutation Carriers
28%
Matrix Metalloproteinases
28%
Protein Staining
28%
BRCA2 mutation
28%
Breast Cancer
28%
Tumor Promotion
28%
Prostate Cancer Cell Lines
28%
Cathepsin B
28%
Cathepsin H
28%
Cathepsin X
28%
Cystatin C (Cys C)
28%
In Cancer
28%
Cancer-testis Antigen
28%
Emerging Therapeutics
28%
Genomic Instability
28%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
81%
Cancer Cell
71%
Cancer Testis Antigen
62%
Genomic Instability
62%
DNA Damage Response
61%
Lactate Dehydrogenase
57%
Immune Checkpoint Inhibitor
33%
Cell Survival
31%
Gene Expression Profiling
30%
Cancer Therapy
29%
Tumor Microenvironment
28%
Neutrophil Collagenase
28%
microRNA
28%
Cell Cycle
28%
Interstitial Collagenase
28%
Genetic Polymorphism
28%
Colorectal Cancer
28%
BRCA1 Protein
28%
Matrix Metalloproteinase
28%
Tumor Promotion
28%
Basal Like Breast Cancer
28%
Long Untranslated RNA
28%
COVID-19
28%
Cathepsin
21%
Methylation
21%
Chemosensitivity
21%
Immune Checkpoint Blockade
17%
Immunogenicity
16%
Breast Tumor
15%
Transcriptomics
14%
Predictive Marker
14%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
AMPK Signaling
11%
Clinical Decision Making
11%
Biological Phenomena and Functions Concerning the Entire Organism
11%
Radiation Therapy
11%
Side Effect
11%
Triple Negative Breast Cancer
10%
Breast Cancer Molecular Subtype
10%
Cisplatin
10%
Olaparib
10%
Immune Response
9%
Prognostic Factor for Breast Cancer
9%
Gelatinase
9%
Cancer Susceptibility
9%
Collagenase
9%
Single Nucleotide Polymorphism
9%
Extracellular Matrix
9%
DNA Polymorphism
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
87%
Neutrophil Collagenase
85%
Genome Instability
59%
Collagenase
38%
Steroid Receptor
33%
DNA Damage Response
32%
Matrix Metalloproteinase
30%
Gene Expression Profiling
30%
Immunogenicity
30%
Tumor-Related Gene
28%
Microarrays
28%
Immunoproteomics
28%
AMPK Signaling
28%
MicroRNA
28%
Carcinogenesis
28%
MMP2
28%
Gelatinase A
28%
Metalloprotease Inhibitor
28%
BRCA1 Protein
28%
BRCA1
28%
Genetic Polymorphism
28%
BRCA2
28%
Lactate Dehydrogenase
28%
Cell Survival
28%
STAT3
28%
Long Non-Coding RNA
28%
Blood Plasma
28%
SARS Coronavirus
28%
CRISPR
22%
Transcriptomics
19%
Serum Total Protein
19%
Decitabine
17%
Promoter Region
17%
Methylation
17%
Chemosensitivity
17%
Warburg Effect
14%
Immunity
14%
Metastasis Suppressor
9%
Differential Gene Expression
9%
Gelatinase
9%
SNAI1
9%
Tumor Antigen
9%
MMP3
9%
ZEB1
9%
Blood Proteins
9%
Downregulation
7%
Demethylation
5%
Drug Concentration
5%
Immunocompetent Cell
5%
Cisplatin
5%